EBENEZER QUAINOO: Open Payments
NPI 1326033952 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 27 payments from 11 companies in 2025. Trend: 2023 $1,203 · 2024 $956 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $116 |
| Exact Sciences Corporation | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Medtronic, Inc. | 3 | $70 |
| PFIZER INC. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lilly USA, LLC | 2 | $42 |
| Novo Nordisk Inc | 2 | $41 |
| Averitas Pharma Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: QULIPTA, Cologuard Collection Kit, MINIMED 780G, BREZTRI, CAPLYTA, MOUNJARO, ELIQUIS, QUTENZA.
Industry payments across MD — which companies pay providers there.
